Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
2005
Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade
2007
Intracellular Nucleic Acid Sensors and Autoimmunity
2011 StandoutNobel
Interleukin-18 and IL-18 Binding Protein
2013
Rituximab therapy for juvenile-onset systemic lupus erythematosus
2007
“Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis
1996
Predictors of disease course and remission in systemic juvenile idiopathic arthritis: Significance of early clinical and laboratory features
2006
Cancer/testis (CT) antigens: Potential targets for immunotherapy
2009
NF-κB signaling in inflammation
2017 Standout
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
2007 Standout
Regulation of Adaptive Immunity; The Role of Interleukin-10
2013
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
2008 Standout
Juvenile idiopathic arthritis
2007 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Treatment of lupus nephritis in children
2000
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
The roles of segmental and tandem gene duplication in the evolution of large gene families in Arabidopsis thaliana
2004 Standout
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
2009
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
Immunotherapeutic Strategies for High-Risk Bladder Cancer
2007 StandoutNobel
Genetic susceptibility to systemic lupus erythematosus in the genomic era
2010
Lupus nephritis in childhood and adolescence
1994
Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease
2020
Caspase Functions in Cell Death and Disease
2013 Standout
Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: Defective rejoining of radioinduced dna strand breaks in lymphocytes of breast cancer patients
1999
Mechanisms of Autoantibody Production in Systemic Lupus Erythematosus
2015
Systemic Lupus Erythematosus
2011 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome
2002
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Update on the genetics of the idiopathic inflammatory myopathies
2000
A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases
2017
Genetic and epigenetic features in radiation sensitivity
2005
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
2017 Standout
Recent insights into the genetic basis of systemic lupus erythematosus
2009
Identification of a New, Unorthodox Member of the MAGE Gene Family
1999
T cell migration in rheumatoid arthritis
2015
Regulatory T cells in tumor immunity
2010 StandoutNobel
Prevalence and incidence of juvenile idiopathic arthritis: A systematic review
2013 Standout
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis
1992
New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment
2007
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Current management of juvenile idiopathic arthritis
2006
Polymyositis and dermatomyositis
2003 Standout
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Cyclosporin A and Therapeutic Plasma Exchange in the Treatment of Severe Systemic Lupus Erythematosus
2000
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies
2009
OrthoParaMap: Distinguishing orthologs from paralogs by integrating comparative genome data and gene phylogenies
2003
Review of recent genome‐wide association scans in lupus
2009
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
2017 Standout
IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis
2019
Aberrant Processing of Oxidative DNA Damage in Systemic Lupus Erythematosus
2000
A Genomic Approach to Human Autoimmune Diseases
2010
Early predictors of outcome in juvenile idiopathic arthritis.
2004
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritis
1995
Large Scale Identification of Human Hepatocellular Carcinoma-Associated Antigens by Autoantibodies
2002
Cytokine Storm
2020 Standout
Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis
1996 Standout
Prevalence and short-term outcome of juvenile idiopathic arthritis: a population-based study in Estonia.
2008
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
The Immune Response in Tuberculosis
2013 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
B Cell and BAFF Dependence of IFN-α–Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice
2011
The cancer/testis genes: review, standardization, and commentary.
2004
The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors.
2000 Standout
The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease
2011
Rheumatic Diseases of Childhood
1990
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Works of Deborah McCurdy being referenced
Plasmin Immunization Preferentially Induces IgG-Anticardiolipin Antibodies That Are Potentially Prothrombotic in MRL/MpJ Mice
2009
Identification of novel susceptibility genes in childhood‐onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform
2007
MAGE-B2 Autoantibody: A New Biomarker for Pediatric Systemic Lupus Erythematosus
2008
Association of IRF5 polymorphisms with activation of the interferon α pathway
2009
mRNA expression of MAGE-A3 gene in leukemia cells
2006
MAGE Xp-2: A Member of the MAGE Gene Family Isolated from an Expression Library Using Systemic Lupus Erythematosus Sera
1998
Genetic susceptibility to the connective tissue diseases
1999
Intermittent intravenous cyclophosphamide therapy for lupus nephritis
1989
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.
2003
Expression of melanoma antigen gene by cells from inflamed joints in juvenile rheumatoid arthritis.
2002
Systemic Lupus Erythematosus in the First Decade of Life
1989
Lupus Nephritis: Prognostic Factors in Children
1992
The antiphospholipid syndrome: immunologic and clinical aspects. Clinical spectrum and treatment.
2000
Delayed Repair of DNA Damage by Ionizing Radiation in Cells from Patients with Juvenile Systemic Lupus Erythematosus and Rheumatoid Arthritis
1997
Coronary arthritis in mice following the systemic injection of group b Lactobacillus casei cell walls in aqueous suspension
1985